Our Pricing

Saxenda Reviews: What Real UK Patients and Clinical Evidence Tell Us

Published on: June 03, 2026

Saxenda reviews from UK patients and clinical trials reveal consistent weight loss outcomes when combined with lifestyle changes, though individual experiences vary significantly. As a UK-registered pharmacy with thousands of patients treated, we've compiled evidence-based insights from clinical data, patient feedback, and our superintendent pharmacist's experience to help you make an informed decision. This comprehensive review examines efficacy, side effects, cost-effectiveness, and real-world results.

Clinical Trial Evidence: What Saxenda Reviews from Research Show

The most robust saxenda reviews come from the SCALE clinical trial programme, which enrolled over 5,000 participants across multiple studies [1]. In the pivotal SCALE Obesity and Prediabetes trial, patients using Saxenda (liraglutide 3mg) alongside reduced-calorie diet and increased physical activity lost an average of 8% of their body weight over 56 weeks, compared to 2.6% in the placebo group [1]. Importantly, 63.2% of Saxenda-treated patients achieved at least 5% weight loss, versus 27.1% on placebo, demonstrating clinically meaningful outcomes for the majority.

Long-term saxenda reviews from the three-year SCALE Maintenance study showed that patients who had already lost weight on a low-calorie diet maintained significantly greater weight loss with Saxenda compared to placebo [2]. These patients lost an additional 6.2% of their initial body weight while on Saxenda, versus gaining 0.2% on placebo. The trial data confirms that Saxenda's effectiveness extends beyond initial weight loss to long-term weight management, a critical factor often overlooked in patient reviews focused solely on rapid results.

Real Patient Saxenda Reviews: Common Experiences from UK Users

Patient saxenda reviews consistently highlight appetite suppression as the primary mechanism of action, with most users reporting reduced hunger and earlier satiety within the first two weeks of treatment. Our clinical team at Cured Pharmacy has observed that patients typically experience noticeable appetite changes at the 1.2mg to 1.8mg dose levels, though the full 3.0mg maintenance dose provides optimal effect for most individuals. Weight loss patterns in real-world saxenda reviews mirror clinical trials, with gradual reduction of 0.5-1kg per week being typical rather than dramatic rapid loss.

Common themes in negative saxenda reviews centre on gastrointestinal side effects, particularly nausea, which affects approximately 40% of users initially [3]. However, patient feedback shows these effects typically diminish after 2-4 weeks as tolerance develops. The slow dose escalation protocol (starting at 0.6mg and increasing weekly) minimises side effects for most patients. Cost concerns feature prominently in UK saxenda reviews, though at £48.00 with code Weightlossnew from Cured Pharmacy, affordability has improved significantly compared to previous market pricing.

Saxenda Reviews: Timeline of Expected Results

Analysing saxenda reviews by treatment duration reveals predictable patterns: weeks 1-2 show minimal weight change but marked appetite reduction; weeks 3-8 typically yield 3-5% body weight loss as patients reach higher doses; months 3-6 produce the most significant results with 5-10% total weight loss in adherent patients; and months 6-12 focus on maintenance and preventing regain [1]. Patients who discontinue Saxenda prematurely, often cited in negative reviews, rarely achieve optimal outcomes, as the medication requires sustained use alongside lifestyle modification for maximum benefit.

Side Effects in Saxenda Reviews: What to Expect and How to Manage Them

Gastrointestinal effects dominate saxenda reviews regarding side effects, with nausea (39.3%), diarrhoea (20.9%), constipation (19.4%), and vomiting (15.7%) being most frequently reported in clinical trials [3]. These effects are dose-dependent and typically transient, with most patients in our experience adapting within the first month. Practical management strategies include taking Saxenda with food despite its subcutaneous administration, staying well-hydrated, avoiding high-fat meals, and not progressing to the next dose level if current side effects are intolerable.

Less common but important side effects mentioned in comprehensive saxenda reviews include injection site reactions (13.9%), headache (13.6%), and hypoglycaemia in patients with type 2 diabetes [3]. Serious adverse events are rare but include pancreatitis risk, gallbladder problems, and increased heart rate. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) emphasises that any persistent abdominal pain, visual changes, or signs of allergic reaction warrant immediate medical attention and treatment discontinuation, as documented in MHRA guidance for liraglutide products.

Saxenda Reviews Compared to Alternative Weight Loss Treatments

Comparative saxenda reviews against newer GLP-1 receptor agonists reveal important distinctions in efficacy and tolerability. Wegovy (semaglutide 2.4mg) demonstrates superior average weight loss of 15% versus Saxenda's 8% in head-to-head comparisons, though both require daily injections versus Wegovy's weekly administration [4]. Mounjaro (tirzepatide), a dual GIP/GLP-1 agonist, shows even greater efficacy with up to 22.5% weight loss in trials, but costs significantly more and requires different clinical considerations [5].

When evaluating saxenda reviews against oral options like Orlistat or Mysimba, the mechanisms differ fundamentally. Orlistat blocks fat absorption and requires strict dietary fat restriction, producing modest 3-5% weight loss, while Saxenda works centrally to reduce appetite with greater average efficacy [6]. Patient preference in reviews often favours Saxenda's appetite suppression over Orlistat's gastrointestinal effects, though cost and administration route influence individual choices. All prescription weight loss treatments available through Cured Pharmacy require clinical assessment by a UK-registered prescriber to ensure suitability and safety.

Cost-Effectiveness in Saxenda Reviews from UK Patients

Financial considerations feature prominently in UK saxenda reviews, as the treatment represents a significant ongoing investment. At Cured Pharmacy's price of £48.00 per pack with code Weightlossnew, monthly costs are substantially lower than many competitors, improving long-term affordability for patients requiring 6-12 months of treatment. When calculating cost per kilogram lost based on average clinical trial results, Saxenda demonstrates reasonable value compared to commercial weight loss programmes, though individual results vary. Patients should factor in the requirement for continuous treatment to maintain weight loss, as discontinuation typically results in weight regain, a common theme in long-term saxenda reviews.

Who Benefits Most: Saxenda Reviews by Patient Profile

Saxenda reviews stratified by patient characteristics reveal that individuals with BMI 30-35 kg/m² and no significant comorbidities often achieve excellent results with good tolerability, while those with BMI over 40 kg/m² may require more intensive interventions or combination therapy. Patients with emotional eating patterns consistently report positive saxenda reviews, as the appetite suppression helps break habitual eating cycles. Conversely, individuals whose weight gain stems primarily from medical conditions like hypothyroidism or PCOS may see more modest results and should address underlying conditions concurrently.

Age-related differences appear in saxenda reviews, with younger adults (18-40 years) often reporting faster initial weight loss but also higher discontinuation rates due to lifestyle factors, while middle-aged patients (40-60 years) demonstrate better long-term adherence and sustained results. Gender differences are minimal in clinical efficacy, though women report nausea slightly more frequently than men in patient reviews [1]. Patients with previous weight loss attempts show varied outcomes, those with yo-yo dieting history often benefit from Saxenda's appetite regulation, while individuals who have never modified diet or exercise may need additional behavioural support alongside medication.

Expert Pharmacist Perspective: Interpreting Saxenda Reviews Accurately

As a UK-registered pharmacy treating thousands of weight loss patients, our experience with saxenda reviews aligns closely with clinical trial data while revealing important real-world nuances. Superintendent pharmacist Tarun Kumar notes that patient expectations significantly influence satisfaction, those expecting rapid dramatic weight loss without lifestyle changes invariably leave negative reviews, while patients understanding Saxenda as a tool supporting calorie reduction and exercise report high satisfaction even with moderate results. The medication works by reducing hunger and increasing satiety, but patients must still create a calorie deficit through dietary choices.

Critical evaluation of online saxenda reviews requires distinguishing between product effectiveness and individual adherence or suitability issues. Reviews citing 'no results' after 2-3 weeks reflect unrealistic timelines, as clinical protocols require 8-12 weeks at maintenance dose for proper assessment. Complaints about side effects without mentioning dose escalation suggest improper administration or lack of clinical guidance. Conversely, reviews describing specific weight loss amounts, timeframes, and lifestyle changes alongside Saxenda use provide more reliable insights. Our clinical team recommends focusing on reviews from patients with similar BMI, age, and health profiles, while recognising that individual responses to any weight loss treatment vary considerably based on genetics, metabolism, and adherence factors [7].

Making an Informed Decision Based on Saxenda Reviews

After reviewing clinical evidence and patient experiences, suitable candidates for Saxenda typically include adults with BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related comorbidities) who have attempted diet and exercise without sustained success, can commit to daily injections for 6-12 months, and accept that results require concurrent lifestyle modification. Saxenda reviews consistently show best outcomes in patients who view the medication as supporting behavioural changes rather than replacing them. All treatment requires prior clinical assessment through Cured Pharmacy's online consultation with a UK-registered prescriber, who will evaluate your medical history, current medications, and suitability for liraglutide therapy before issuing a prescription. Starting at £48.00 with code Weightlossnew, Saxenda represents an evidence-based option with robust clinical data and generally positive patient experiences when used appropriately.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 13 August 2026]
2. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451. [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen - Summary of Product Characteristics. Novo Nordisk Limited. [accessed 13 August 2026]
4. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (CG189). NICE Clinical Guideline. [accessed 13 August 2026]
7. Medicines and Healthcare products Regulatory Agency. (2023). Glucagon-like peptide-1 (GLP-1) receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(9). [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.